University of Chicago
Locations
Transplant Summary
Overview
We are committed to excellence in patient care, research and education. Our multidisciplinary care team offers expertise and compassion. Our research team is at the forefront of improvements in conditioning regimens and alternative donor transplants including cord and mismatched donor transplant. We have several programs and features unique to our center, including the Adolescent and Young Adult Program (AYA), Transplant Optimization Program (TOP) for our older adult patients, and an outpatient stem cell transplant unit which allows us to offer outpatient transplant to eligible patients. We also perform haplo and mismatched unrelated donor transplant or cord transplant for patients who do not have a fully matched donor.This center has been performing allogeneic transplants since 1985 and has been an NMDP transplant center since October 2001.
Attending physicians
Adult - Michael R. Bishop, Jennifer Cooperrider, Ben Derman, Adam DuVall, Andrzej Jakubowiak, Justin Kline, Satyajit Kosuri, Richard Larson, Mariam Nawas, Peter Riedell, Gregory Roloff, Sonali Smith, Wendy Stock
Pediatric - Rohini Chakravarthy, John Cunningham, Saara Kaviany, James LaBelleTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult and pediatricOther programs and services
During treatment at UCM, patients and their families may receive a discount at many Chicago hotels. You can find a complete listing on our hotel page or by calling UCM Connect at 1-888-824-0200. Also, the nearby Ronald McDonald House is available on a first-come, first-served basis to those who meet the selection criteria. We also have 2 apartment units located in our Hyde Park campus for patient use during transplant. We also have our Center for International Patients which provides personalized and coordinated medical care to patients coming from abroad. Our international office is staffed 24 hours a day, 7 days a week to assist with interpreter services, travel arrangements and hotel accommodations, transportation needs, medical visa applications, and arranging cultural and leisure activities for patients and their families.Patient survival information for this center
Comer Children's Hospital/University of Chicago Medicine
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 19 patients.The actual 1-year survival of these patients is 89.5%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 65.5% and 97.2%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.University of Chicago Medicine
This center's actual 1-year survival results are below the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 131 patients.The actual 1-year survival of these patients is 67.8%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 69.3% and 83.4%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
272
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total Marrow2PBSC34Cord blood0Total36Marrow0PBSC70Cord blood3Total73Marrow2PBSC104Cord blood3Total109MarrowBoth marrow & PBSC 163PBSC—Cord blood—Total163MarrowBoth marrow & PBSC 269PBSC—Cord blood3Total272Total pediatric transplants
37
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total Marrow6PBSC2Cord blood0Total8Marrow4PBSC5Cord blood1Total10Marrow10PBSC7Cord blood1Total18MarrowBoth marrow & PBSC 19PBSC—Cord blood—Total19MarrowBoth marrow & PBSC 36PBSC—Cord blood1Total37All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18719-44845-641965+10Total44Unrelated 0-18919-442545-642865+21Total83Autologous 0-182019-443745-647465+51Total182Total 0-183619-447045-6412165+82Total309Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
Transplant center coordinatorMylove MortelPhone: (773) 316-2023If you have questions about costs and financial services at this center, please call the transplant center’s direct phone number.NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
No survivorship program information is available. Contact the center for information about post-transplant care.